A pilot study of once daily, outpatient antibiotic therapy for low-risk patients with neutorpenic fever
Phase of Trial: Clinical Phase Unknown
Latest Information Update: 18 Jan 2006
At a glance
- Drugs Moxifloxacin (Primary)
- Indications Bacterial infections; Febrile neutropenia
- Focus Adverse reactions
- 18 Jan 2006 New trial record.